Skip to search
Skip to main content
Back to Search
Start Over
Randomized comparison of pazopanib (PAZ) and doxorubicin (DOX) in the first line treatment of metastatic soft tissue sarcoma (STS) in elderly patients (pts): Results of a phase II study (EPAZ).
Authors :
Grunwald, Viktor Kunitz, Annegret Schuler, Markus Kajo Schoffski, Patrick Kopp, Hans-Georg Bauer, Sebastian Kasper, Bernd Lindner, Lars H. Chemnitz, Jens-Marcus Crysandt, Martina Margrit Stein, Alexander Steffen, Bjoern Egerer, Gerlinde Zimmermann, Silke Karch, Annika Grunwald, Viktor Kunitz, Annegret Schuler, Markus Kajo Schoffski, Patrick Kopp, Hans-Georg Bauer, Sebastian Kasper, Bernd Lindner, Lars H. Chemnitz, Jens-Marcus Crysandt, Martina Margrit Stein, Alexander Steffen, Bjoern Egerer, Gerlinde Zimmermann, Silke Karch, Annika
Publication Year :
2018
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1201319619
Document Type :
Electronic Resource